Apollo Hospitals Enterprise Ltd stock (INE438A01022): Hits new 52-week high

Apollo Hospitals Enterprise Ltd reached a new 52-week high of Rs 8,129.9 on June 11, 2026, amid broad technical strength and sustained buying interest.

Apollo Hospitals Enterprise Ltd stock surged to a new 52-week high of Rs 8,129.9 on June 11, 2026, breaking decisively above Rs 8,100, according to MarketsMojo as of June 11, 2026. The healthcare provider's shares gained 4.36% over the prior three trading sessions, trading above all key moving averages, signaling strong upward momentum.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Apollo Hospitals Enterprise Ltd
• Sector/industry: Healthcare
• Headquarters/country: India
• Core markets: India
• Key revenue drivers: Hospitals, pharmacies, digital health
• Home exchange/listing venue: NSE (APOLLOHOSP)
• Trading currency: INR

Apollo Hospitals Enterprise Ltd: core business model

Apollo Hospitals Enterprise Ltd operates India's largest integrated healthcare provider, with a network of hospitals, pharmacies, and digital health services. Founded in 1983, the company manages over 70 hospitals across India and has expanded into primary care and diagnostics. Its model integrates tertiary care with retail pharmacies under Apollo Pharmacy and telehealth via Apollo 24/7, serving millions of patients annually.

The business emphasizes high-quality care in oncology, cardiology, and orthopedics, with a focus on medical tourism attracting international patients, including from the US. Revenue stems primarily from hospital operations, which account for the majority of income, supplemented by pharmacies contributing steady cash flow.

Main revenue and product drivers for Apollo Hospitals Enterprise Ltd

Hospitals form the core revenue driver, generating the bulk of sales through inpatient and outpatient services. In recent quarters, the company has shown steady earnings growth, underpinning the recent price rally, as noted in technical analyses. Pharmacies and diagnostics provide resilient margins amid rising healthcare demand in India.

Digital health initiatives like Apollo 24/7 have boosted growth, with app-based consultations and home care services expanding reach. Over the past year, the stock delivered 20.72% returns from a 52-week low of Rs 6,680, outperforming the Sensex's decline of 3.93%, per MarketsMojo as of June 11, 2026.

Industry trends and competitive position

India's healthcare sector is expanding rapidly due to rising incomes, aging population, and government initiatives like Ayushman Bharat. Apollo Hospitals Enterprise Ltd holds a leading position with its scale and brand, facing competition from Max Healthcare and Fortis but differentiating through its integrated ecosystem. The sector's growth supports long-term demand for hospital beds and specialty care.

Why Apollo Hospitals Enterprise Ltd matters for US investors

US investors gain exposure to India's booming healthcare market via Apollo Hospitals Enterprise Ltd, listed on the NSE and accessible through ADRs or global funds. With medical tourism links to the US and digital health innovations, the company offers diversification into emerging market growth, relevant amid US healthcare cost pressures.

Conclusion

Apollo Hospitals Enterprise Ltd's recent 52-week high reflects technical strength and underlying earnings stability in India's healthcare sector. The stock's outperformance versus benchmarks highlights investor confidence, though it slightly trailed its sector on the peak day. US investors may note its role in emerging market healthcare growth.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.